INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial

BACKGROUND: The effectiveness of erythropoiesis-stimulating agents, which are the main stay of managing anaemia of chronic kidney disease (CKD), is largely dependent on adequate body iron stores. The iron stores are determined by the levels of serum ferritin concentration and transferrin saturation....

Descripción completa

Detalles Bibliográficos
Autores principales: Majoni, Sandawana William, Nelson, Jane, Germaine, Darren, Hoppo, Libby, Long, Stephanie, Divakaran, Shilpa, Turner, Brandon, Graham, Jessica, Cherian, Sajiv, Pawar, Basant, Rathnayake, Geetha, Heron, Bianca, Maple-Brown, Louise, Batey, Robert, Morris, Peter, Davies, Jane, Fernandes, David ( Kiran), Sundaram, Madhivanan, Abeyaratne, Asanga, Wong, Yun Hui Sheryl, Lawton, Paul D., Taylor, Sean, Barzi, Federica, Cass, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641231/
https://www.ncbi.nlm.nih.gov/pubmed/34857020
http://dx.doi.org/10.1186/s13063-021-05854-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641231/
https://www.ncbi.nlm.nih.gov/pubmed/34857020
http://dx.doi.org/10.1186/s13063-021-05854-w

Ejemplares similares